Department of Biostatistics and Epidemiology, Amgen Inc, Thousand Oaks, CA, USA.
Nephrol Dial Transplant. 2011 Nov;26(11):3659-66. doi: 10.1093/ndt/gfr063. Epub 2011 Mar 3.
The excess morbidity and mortality related to catheter utilization at and immediately following dialysis initiation may simply be a proxy for poor prognosis. We examined hospitalization burden related to vascular access (VA) type among incident patients who received some predialysis care.
We identified a random sample of incident US Dialysis Outcomes and Practice Patterns Study hemodialysis patients (1996-2004) who reported predialysis nephrologist care. VA utilization was assessed at baseline and throughout the first 6 months on dialysis. Poisson regression was used to estimate the risk of all-cause and cause-specific hospitalizations during the first 6 months.
Among 2635 incident patients, 60% were dialyzing with a catheter, 22% with a graft and 18% with a fistula at baseline. Compared to fistulae, baseline catheter use was associated with an increased risk of all-cause hospitalization [adjusted relative risk (RR) = 1.30, 95% confidence interval (CI): 1.09-1.54] and graft use was not (RR = 1.07, 95% CI: 0.89-1.28). Allowing for VA changes over time, the risk of catheter versus fistula use was more pronounced (RR = 1.72, 95% CI: 1.42-2.08) and increased slightly for graft use (RR = 1.15, 95% CI: 0.94-1.41). Baseline catheter use was most strongly related to infection-related (RR = 1.47, 95% CI: 0.92-2.36) and VA-related hospitalizations (RR = 1.49, 95% CI: 1.06-2.11). These effects were further strengthened when VA use was allowed to vary over time (RR = 2.31, 95% CI: 1.48-3.61 and RR = 3.10, 95% CI: 1.95-4.91, respectively). A similar pattern was noted for VA-related hospitalizations with graft use. Discussion. Among potentially healthier incident patients, hospitalization risk, particularly infection and VA-related, was highest for patients dialyzing with a catheter at initiation and throughout follow-up, providing further support to clinical practice recommendations to minimize catheter placement.
与导管利用相关的过多发病率和死亡率可能只是预后不良的一个指标。我们研究了在接受一些透析前护理的新发病例患者中血管通路 (VA) 类型相关的住院负担。
我们确定了美国透析结果和实践模式研究中接受透析前肾病医生护理的随机新发病例血液透析患者样本 (1996-2004 年)。在基线和透析开始后的头 6 个月内评估 VA 利用情况。使用泊松回归估计前 6 个月内全因和特定病因的住院风险。
在 2635 名新发病例患者中,60%在基线时使用导管进行透析,22%使用移植物,18%使用瘘管。与瘘管相比,基线时使用导管与全因住院风险增加相关[调整后的相对风险 (RR) = 1.30,95%置信区间 (CI):1.09-1.54],而使用移植物则没有 (RR = 1.07,95% CI:0.89-1.28)。随着时间的推移允许 VA 变化,导管与瘘管相比的风险更为明显 (RR = 1.72,95% CI:1.42-2.08),而移植物的风险略有增加 (RR = 1.15,95% CI:0.94-1.41)。基线导管的使用与感染相关的 (RR = 1.47,95% CI:0.92-2.36) 和 VA 相关的住院治疗最为相关 (RR = 1.49,95% CI:1.06-2.11)。当允许 VA 在整个随访过程中变化时,这些影响进一步加强 (RR = 2.31,95% CI:1.48-3.61 和 RR = 3.10,95% CI:1.95-4.91)。移植物使用时 VA 相关住院治疗也出现了类似的模式。讨论:在潜在更健康的新发病例患者中,导管起始和整个随访期间导管透析患者的住院风险最高,特别是感染和 VA 相关风险,这为临床实践建议提供了进一步支持,以尽量减少导管放置。